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Method andmaterials: We were observed 316 (male)
student, who arrived from all province of Mongolia in
Ulaanbaatar. They are divided into 4 groups by date of
birth: 1. Born before 1987; 2. Born in 1988 89; 3. Born in
1990; 4. Born after 1991 (after launching HBV vaccination),
In all serum samples tested for HBsAg, anti-HBc and anti-HBs
by ELISA.







1 44 6.8 34.1 34.1
2 111 5.4 27.9 27.0
3 71 7.0 21.1 22.5
4 91 3.3 6.6 14.3
The data in the table show that, the exposure ofHBV
infection in non vaccinated more than 20%, then vaccinated
populations less than 7%.
Conclusion: The exposure and prevalence rate of HBV
infection signiﬁcant difference in vaccinated and non
vaccinated population.
PP-120 Cloning and screening transregulated genes of
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Objective: To screen and identify human genes transac-
tivated by HBEBP2 by constructing a cDNA subtractive
library with suppression subtractive hybridization (SSH)
technique.
Methods: pcDNA3.1( )-myc-his-HBEBP2 was constructed.
Then the L02 cells was transfected by pcDNA3.1( )-myc-
his-HBEBP2 and pcDNA3.1( )-myc-his empty vector, and
SSH method was employed to analyze the differentially
expressed DNA sequence between the two groups. After
restriction enzyme Rsa I digestion, small sizes cDNAs were
obtained. Then tester cDNA was divided into two groups and
ligated to the speciﬁc adaptor 1 and adaptor 2, respectively.
Aftertester cDNA was hybridized with driver cDNA twice
and underwent two times of nested PCR, the second PCR
production was subcloned into pGEM-Teasy plasmid vectors
to set up the subtractive library. Ampliﬁcation of the library
was transformed into E. coli. The cDNA was sequenced and
analyzed in GenBank with Blastn search after PCR.
Results: The subtractive library of genes transactivated
by HBEBP2 was constructed successfully. The ampliﬁed
library contains 80 positive clones containing 200 bp-1000
bp inserts. Sequence analysis was performed in 26 clones
randomly, and the full length sequences were obtained with
bioinformatics method. Altogether 7coding sequences were
gotten.
Conclusions: The obtained sequences may be target genes
transactivated by HBEBP2, and some genes coding proteins
involved in metabolism, autoimmunity regulation, protein
modiﬁcation, cell cycle regulation.
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Objective: To construct the eukaryotic expression vector of
HBEBP1 gene and express HBEBP1 recombinant protein in
yeast.
Methods: PCR was performed to amplify the gene of HBEBP1
from the cDNA template origining from HepG2, and the
gene was cloned into pGEM-T vector. After sequencing,
the correct DNA fragment was cut from pGEM-T-HBEBP1
and inserted into yeast expression plasmid pGBKT7. The
reconstructed plasmid pGBKT7-HBEBP1 was transformed
into yeast cell AH109 and screened on the synthetic dropout
nutrient medium (SD/-Trp/Kana). The yeast protein was
isolated and analyzed with SDS-PAGE and Western blot.
Results: The eukaryotic expressive vector was constructed
successfully. The results of Western blot showed HBEBP1
protein was existed within yeast cells and the molecular
weight of it was about 32.3kD.
Conclusions: The successful expression of HBEBP1 protein
in yeast cells lay the foundation for studying biological
function of HBEBP1.
PP-122 Association between IRF-3 polymorphisms and
susceptibility to chronic hepatitis B virus
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Y.F. Gao1 *, F. Yan1. 1Department of hepatology, the second
afﬂiated hospital of Anhui Medical University, China
Aim: To investigate the association between the three
tagSNPs (rs10415576, rs2304204, rs2304206) of IRF3 gene
and genetic susceptibility of chronic hepatitis B virus (HBV)
infection in Chinese patients.
Materials and Methods: Based on the case-control study
in 985 case of chronic HBV infection and 294 self-limiting
HBV infection individuals as controls, three tagSNPs in the
IRF3 gene were genotyped by Multiplex Snapshot technique.
The genotype and allele frequencies were calculated and
analyzed.
Results: The three SNPs sites showed no signiﬁcant
genotyping/allelic associations with chronic HBV infection.
Overall allelic P values: rs10415576, P= 0.0908, OR
(95%CI) = 1.1798 (0.9740 1.4291); rs2304204, P= 0.5959,
OR (95%CI) = 1.0597 (0.8552 1.3133); rs2304206, P= 0.8372,
OR (95%CI) = 1.0250 (0.8097 1.2976). Overall genotype
P values: rs10415576, P= 0.2106; rs2304204, P= 0.8458;
rs2304206, P= 0.8315. There was no statistically signiﬁcant
difference between chronic HBV infection and controls.
Haplotypes generated by these three SNPs did not show
signiﬁcantly difference between the two groups either
(P> 0.05).
Conclusion: The data suggest that the three tagSNPs sites of
IRF3 gene are not associated with HBV infection in Chinese
Han population.
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Objective: To study the relationship between HBeAg and
persistence of HBV infection.
Methods: Taking HBeAg negative CHB patients as the
research objects, determined the expression of B7-H1/PD-1
and TLR-2 on CD14+ PBMCs and IFN-g and IL-4 in CD3+CD4+
cells before and after incubation with HBeAg and TLR-2
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on CD14+ PBMCs under the stimulation of HBeAg with or
without anti-HBe antibody by ﬂow cytometry.
Results: Both in CHB patients and healthy people, TLR-2
decreased signiﬁcantly (t scores were 4.948 and 3.245, both
P values were below 0.05) and B7-H1 increased (t scores
were 3.612 and 2.341, both P values were below 0.05)
and IFN-g decreased signiﬁcantly (CHB group, t = 2.184 and
P = 0.050, healthy control group, t = 2.800 and P = 0.030)
after incubation with HBeAg. TLR-2 also decreased under
the stimulation of HBeAg with anti-HBe antibody, but there
was no statistical difference compared with incubation with
HBeAg alone (P > 0.05).
Conclusions HBeAg could increase the negative
costimulatory molecule B7-H1, inhibit TLR-2 and IFN-g,
these lead to the reduced capacity of speciﬁc CTLs in viral
clearance.
PP-124 The variation of HBsAg titre in patients with
chronic hepatitis B, HBV-related liver cirrhosis
and hepatocellular carcinoma
Y.Z. Pei1,2 *, T. Han1,2, X.Y. Ma1,2, Y. Li1, J. Xing1,2,
Z.L. Song1. 1Tianjin Third Central Hospital, 2Tianjin
Medical University, China
Objective: To analyze HBsAg titre variational tendency in
patients with chronic hepatitis B (CHB), HBV-related liver
cirrhosis (LC) and hepatocellular carcinoma (HCC), and the
correlation with HBV DNA in each disease.
Methods: HBsAg titre and HBV DNA were measured
in 47 CHB, 72 LC and 54 HCC patients used Abbott
chemiluminescence and a real-time PCR respectively.
Results: HBsAg titre level in serum decreased from
CHB [2361.10 (975.69 5427.96) IU/mL] to LC [1001.64
(318.72 1819.99) IU/mL] and HCC [594.35 (133.75 1337.00)
IU/mL], and there were statistically signiﬁcant different
(c2 = 24.394, P < 0.001). Moreover, HBsAg titre was
signiﬁcantly higher in CHB than LC (Z = 3.754, P < 0.001),
CHB had signiﬁcantly higher HBsAg titre than HCC
(Z = 4.630, P < 0.001), however, LC and HCC had no
statistically signiﬁcant different (Z = 1.720, P = 0.085).
In HBeAg positive patients, HBsAg titre decreased from
CHB [3259.83 (1710.60 7547.85) IU/mL] to LC [1077.30
(374.39 2553.59) IU/mL] and HCC [789.72 (162.97 1470.95)
IU/mL], and there were signiﬁcant different (c2 = 15.643,
P < 0.0001). In HBeAg negative patients, the decline
of HBsAg titre among CHB [1669.00 (240.78 2920.97)
IU/mL] to LC [1001.64 (115.91 1609.59) IU/mL] and HCC
[582.05 (133.75 1209.07) IU/mL] had signiﬁcant different
(c2 = 6.423, P = 0.04). Correlation between HBsAg titre
and HBV DNA was found in CHB (r = 0.297, P = 0.043),
LC (r = 0.346, P = 0.003) and HCC (r = 0.452, P = 0.001),
respectivly.
Conclusion: HBsAg titre level in serum decreased
progressively from CHB to LC and HCC group. There were
positive correlations between HBsAg titre and HBV DNA level
in CHB, LC and HCC.
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Objectives: Investigate the efﬁcacy of a Chinese herbal
compound prescription (CHCP) for 32 HBeAg positive chronic
hepatitis patients’ two year anti-HBV infection treatments.
Methods: The main ingredients of the CHCP have Chaihu,
Huangqi and Diding. The main prescription consists of 11
herbal ingredients, which was used for all patients. The
sub-prescription consists of 2 4 herbal ingredients, which
was used for patients based on their different symptoms.
The patients took the decocted CHCP two times each day
at least half one hour after meals.
Results: Of 32 CHCP-treated patients, ten (31.2%) have
obtained HBeAg seroconversion, ALT normalization, and with
HBV DNA <1000copies/mL (lower limit of detection). These
patients’ baseline average characters were Age = 25.8 years
old, ALT = 197.74U/L, HBV DNA = 5.71e7 copies/ml, and
HBeAg = 551.25S/CO. The average time to achieve HBV DNA
<1000 copies/ml was 72 weeks. The other 22 CHCP-treated
patients’ baseline average characters were Age = 35.5 years
old, ALT = 148.75U/L, HBV DNA = 4.26e7copies/ml, and
HBeAg = 796.99S/CO. For all CHCP-treated patients, neither
demonstrated substitutions associated with NTCB resistance
or the common adverse events and renal events.
Conclusion: Two years CHCP anti-HBV Infection therapy
is quite effective for the HBeAg positive younger patients
whose baseline ALT >200U/L, HBeAg <500S/CO, and HBV DNA
<1e8copies/ml. The CHCP is safe for long-term’s anti-HBV
infection personalized therapy.
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PP-126 Regulation of TLRs, PD-1/PD-L1 expression and
cytokine secretion on peripheral monocytes by
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Background: HBeAg is important for establishment of
persistent infection. The aim of this study was to detect
the regulation of TLRs, PD-1/PD-L1 expression and cytokine
secretion on PBMCs by HBeAg.
Methods: Anti-HBe serum was collected from CHB with
anti-HBe positive; PBMCs were isolated from healthy
persons; Cytokines secretion were detected by CBA; RT-
PCR examined TLR2, TLR4mRNA.
Result: CD14+ PBMCs of TLR2 was signiﬁcantly reduced
in HBeAg-group compared to control (p = 0.003). TLR4
expression on CD3+ cells in HBeAg-group was signiﬁcantly
decreased, but expressions of PD-1 and PD-L1 were
signiﬁcantly up-regulation; However, when HBeAg was
reactivity against by Anti-HBe, the expression of TLR4, PD-1,
PD-L1 on CD14+ cells and CD3+ cells were improved. At the
same time, cytokines expression were detected, HBeAg was
able to signiﬁcantly down-regulate IL-2, IL-17 and IFN-g,
but up-regulate IL-10 (P< 0.005). RT-PCR illustrated that
HBeAg was able to signiﬁcantly down-regulate TLR2 mRNA
on PBMCs (p = 0.001), while HBeAg was blocked with anti-
HBe, the expression TLR2 mRNA was improved (p < 0.05).
Conclusion: HBeAg was able to signiﬁcantly suppress TLR2
and TLR4 expression and mRNA on CD14+ PBMCs and
PD-L1/PD-1 expressions on PBMCs, yet HBeAg blocked
with anti-HBe could improve the expression of mRNA and
decrease the expression of PD-L1 and PD-1; HBeAg was able
to signiﬁcantly down-regulate proinﬂammatory cytokines.
These results promoted that HBeAg may be through the
way suppressed expression of inﬂammatory factors genes
induced by TLRs signal pathway and regulated secretion
of cytokines to establish persistent infection in chronic
hepatitis B patients.
